AbbVie (NYSE:ABBV), a global research and development-based biopharmaceutical company, announced the expansion of its partnership with BioLabs by becoming the founding sponsor of the new BioLabs University of Toronto. The AbbVie and BioLabs collaboration will accelerate important life science research, with the goal of benefiting people living with serious diseases.